EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency—a comprehensive review

Shengnan Tian, Yang Song, Lixue Liu, Shanshan Chen, Shuxia Wu, Ya Tuo

Frontiers in Microbiology · 27.07.2026 · 17

DOI: 10.3389/fmicb.2026.1856217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 27.07.2026. Verfasst von Shengnan Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) is a chronic condition affecting approximately 1.1–3.7% of women worldwide. Beyond its primary impact on fertility, POI poses significant long-term health risks, including cardiovascular disease, osteoporosis, and neurocognitive decline. Current clinical interventions, largely limited to hormone replacement therapy, are primarily palliative and do not address the underlying depletion of ovarian reserve. Recent research has identified a potential link between gut microbiota and POI pathogenesis, suggesting that gut–ovary axis dysbiosis may play a pivotal role. Systemic depletion of butyrate-producing microbiota has been shown to induce oxidative stress and granulosa cell apoptosis. In this review, we propose the gut–butyrate–SIRT1–FoxO1 axis as a central theoretical framework. This model advances beyond the conventional “leaky gut–LPS inflammation” model to demonstrate that gut-derived butyrate functions as a trans-organ “metabolic messenger.” Through epigenetic–metabolic coupling, butyrate orchestrates SIRT1–FoxO1 activation. This pathway may mitigate reactive oxygen species (ROS)-induced calcium overload, restore mitochondrial quality control, and preserve granulosa cell homeostasis. Recent preclinical studies have demonstrated that butyrate supplementation can rescue ovarian function in POI models by enhancing SIRT1-mediated FoxO1 deacetylation, This mechanism may suppress pro-apoptotic signaling and promote follicular survival. Furthermore, fecal microbiota transplantation (FMT) from healthy donors has been shown to mitigate ovarian senescence in mice with dysbiotic intestinal microbiota, further substantiating the therapeutic potential of this axis. This review delineates the pleiotropic effects of butyrate across multiple organ systems and provides a robust biological foundation for future microbiota-based interventions. Although substantial experimental validation remains necessary, a deeper understanding of this signaling axis has the potential to transform POI clinical management. Future approaches may shift from palliative, symptomatic treatment to precise disease-modifying therapy.

Schlagwörter

Stichwörter der Autor:innen

SIRT1/FOXO1butyrateepigenetic reprogramminggut microbiotagut-ovary axis

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Department of Gynecology, The Fifth People's Hospital of Jinan, Jinan, Shandong, China.
  • Key Laboratory of Reproductive Health Diseases Research and Translation of Ministry of Education & Key Laboratory of Human Reproductive Medicine and Genetic Research of Hainan Province & Hainan Provincial Clinical Resea…

Zitieren

APA

Tian, S., Song, Y., Liu, L., Chen, S., Wu, S., & Tuo, Y. (2026). Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency—a comprehensive review. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1856217

Vancouver

Tian S, Song Y, Liu L, Chen S, Wu S, Tuo Y. Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency—a comprehensive review. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1856217

BibTeX
@article{Tian2026,
  author = {Tian, Shengnan and Song, Yang and Liu, Lixue and Chen, Shanshan and Wu, Shuxia and Tuo, Ya},
  title = {Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency—a comprehensive review},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1856217}
}
Kostenlos starten →